Boji Medical Technology Co.,Ltd.

SZSE:300404 Stock Report

Market Cap: CN¥3.1b

Boji Medical TechnologyLtd Future Growth

Future criteria checks 5/6

Boji Medical TechnologyLtd is forecast to grow earnings and revenue by 76.6% and 29.2% per annum respectively while EPS is expected to grow by 75.5% per annum.

Key information

76.6%

Earnings growth rate

75.53%

EPS growth rate

Life Sciences earnings growth29.7%
Revenue growth rate29.2%
Future return on equityn/a
Analyst coverage

Low

Last updated24 Mar 2025

Recent future growth updates

No updates

Recent updates

Is Boji Medical TechnologyLtd (SZSE:300404) Using Too Much Debt?

Mar 11
Is Boji Medical TechnologyLtd (SZSE:300404) Using Too Much Debt?

Investors Still Aren't Entirely Convinced By Boji Medical Technology Co.,Ltd.'s (SZSE:300404) Revenues Despite 25% Price Jump

Feb 17
Investors Still Aren't Entirely Convinced By Boji Medical Technology Co.,Ltd.'s (SZSE:300404) Revenues Despite 25% Price Jump

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Nov 02
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Oct 08
A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

May 01
Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Mar 06
Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Earnings and Revenue Growth Forecasts

SZSE:300404 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,199128N/A811
12/31/202593299N/A581
3/31/2025713163251N/A
12/31/202474229-327N/A
9/30/202475345-1022N/A
6/30/202466537648N/A
3/31/202462029-3120N/A
12/31/202355624-2636N/A
9/30/202350429-6818N/A
6/30/202348130-1020N/A
3/31/202345327-10215N/A
1/1/202342428-9028N/A
9/30/202238827-7923N/A
6/30/202237940-4540N/A
3/31/202234344-3036N/A
1/1/202232439-2430N/A
9/30/2021298311158N/A
6/30/2021271192164N/A
3/31/20212953068105N/A
12/31/2020260176697N/A
9/30/2020259201855N/A
6/30/202024116537N/A
3/31/2020209-1-37-5N/A
12/31/20192247-290N/A
9/30/20192017123N/A
6/30/20191895532N/A
3/31/20191774-2211N/A
12/31/20181727N/A27N/A
9/30/2018155-16N/A27N/A
6/30/2018153-19N/A32N/A
3/31/2018152-16N/A53N/A
12/31/2017131-24N/A26N/A
9/30/2017121-3N/A-3N/A
6/30/20171034N/A-19N/A
3/31/201774-1N/A-28N/A
12/31/2016722N/A-34N/A
9/30/20168111N/A-19N/A
6/30/20168812N/A-18N/A
3/31/201611122N/A-2N/A
12/31/201512726N/A2N/A
9/30/201515039N/A35N/A
6/30/201515339N/A37N/A
3/31/201514839N/A28N/A
12/31/201414438N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300404's forecast earnings growth (76.6% per year) is above the savings rate (2.7%).

Earnings vs Market: 300404's earnings (76.6% per year) are forecast to grow faster than the CN market (23.7% per year).

High Growth Earnings: 300404's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300404's revenue (29.2% per year) is forecast to grow faster than the CN market (12.4% per year).

High Growth Revenue: 300404's revenue (29.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300404's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 22:33
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Boji Medical Technology Co.,Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siao YeEverbright Securities Co. Ltd.
Kehan MengHaitong International Research Limited